Updated
Everex Next Short-Term Move Mapped (~70% Target)
Here we have a short-term chart for Enigma (ENGBTC).
Prices are now moving above EMA100 on increasing volume and bullish indicators, telling us that this altcoin pair can easily continue to grow.
Below the trade details:
----------
@BCREGBOT | PAIR: Everex | EVXBTC
ENTRY: 0.00002100 - 0.00002350
TP1: 0.00002550
TP2: 0.00002710
TP3: 0.00003100
TP4: 0.00003500
TP5: 0.00003900
STOP: Close 4h candle below 0.00001950.
----------
Thanks a lot for reading.
This is not financial advice.
Namaste.
Prices are now moving above EMA100 on increasing volume and bullish indicators, telling us that this altcoin pair can easily continue to grow.
Below the trade details:
----------
@BCREGBOT | PAIR: Everex | EVXBTC
ENTRY: 0.00002100 - 0.00002350
TP1: 0.00002550
TP2: 0.00002710
TP3: 0.00003100
TP4: 0.00003500
TP5: 0.00003900
STOP: Close 4h candle below 0.00001950.
----------
Thanks a lot for reading.
This is not financial advice.
Namaste.
Note
ENTRY: 0.00002100 - 0.00002350TP1: 0.00002550 |Hit
TP2: 0.00002710 |Hit
TP3: 0.00003100 |Next target
TP4: 0.00003500
TP5: 0.00003900
🚨 The difference between poor weak signals & PREMIUM trade-numbers lies in results. Stand apart from the crowd. #1 Since 2017. Join now 👉 t.me/lamatrades/4
🎯 LIFETIME Results: t.me/anandatrades/1183
(Click & Claim Your FREE Pizza! 🍕)
🎯 LIFETIME Results: t.me/anandatrades/1183
(Click & Claim Your FREE Pizza! 🍕)
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
🚨 The difference between poor weak signals & PREMIUM trade-numbers lies in results. Stand apart from the crowd. #1 Since 2017. Join now 👉 t.me/lamatrades/4
🎯 LIFETIME Results: t.me/anandatrades/1183
(Click & Claim Your FREE Pizza! 🍕)
🎯 LIFETIME Results: t.me/anandatrades/1183
(Click & Claim Your FREE Pizza! 🍕)
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.